Al-Dawaa Medical Services Company (4163.SR) — Cash flow
Operating, investing, and financing cash flow for Al-Dawaa Medical Services Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 322↓13.1% | 370↑12.4% | 329↑3.6% | 318↑29.2% | 246 | |
| Depreciation & Amortization | 417↑8.9% | 383↑5.2% | 364↑2.6% | 355↑6.2% | 334 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -192↓117.4% | -88↓491.7% | -15↓110.2% | 146↑0.6% | 146 | |
| Accounts Receivable | 174↑158.4% | -299↓129.9% | -130↓88.6% | -69↓304.3% | 34 | |
| Inventory | -227↓17.6% | -193↑15.5% | -228↓190.0% | 253↑3251.9% | -8 | |
| Accounts Payable | -197 | 0.00↓100.0% | 289↑9281.6% | 3↓95.9% | 76 | |
| Other Working Capital | 58↓85.6% | 403↑643.7% | 54↑232.3% | -41↓193.1% | 44 | |
| Other Non-Cash Items | 113↑501.9% | 19↓60.5% | 48↑217.9% | -40↑26.8% | -55 | |
| Net Cash from Operating Activities | 660↓3.4% | 683↓5.8% | 726↓6.8% | 778↑16.1% | 670 | |
| Operating Cash Flow | 660↓3.4% | 683↓5.8% | 726↓6.8% | 778↑16.1% | 670 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -152↑32.0% | -223↓2.9% | -217↑24.6% | -288↑10.2% | -320 | |
| Capital Expenditure | -148↑35.4% | -229↓2.3% | -224↑22.2% | -288↑10.2% | -320 | |
| Acquisitions | 0.96↑295.4% | -0.49↓117.4% | 3↓41.7% | 5↓29.7% | 7 | |
| Purchases of Investments | -15 | 0.00 | 0.00 | 0.00↑100.0% | -77 | |
| Sales & Maturities of Investments | 2↓98.6% | 130↑147.4% | 53 | 0.00↓100.0% | 17 | |
| Other Investing Activities | 0.00↑100.0% | -5↑33.7% | -7↑82.1% | -38↓581.4% | -6 | |
| Net Cash from Investing Activities | -164↓67.1% | -98↑41.7% | -168↑40.5% | -283↑25.3% | -378 | |
| Financing Activities | ||||||
| Net Debt Issuance | -40↑77.8% | -182↑28.2% | -253↓462.0% | -45↑77.0% | -195 | |
| Long-Term Net Debt Issuance | -140↑13.1% | -162↓65.1% | -98↓147.8% | 205↑146.0% | -445 | |
| Short-Term Net Debt Issuance | 100↑600.2% | -20↑87.1% | -155↑65.2% | -445↓278.0% | 250 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -214↓0.3% | -213↑0.0% | -213↓101.2% | -106↑69.9% | -351 | |
| Common Dividends Paid | -214↓0.3% | -213↑0.0% | -213↓101.2% | -106↑69.9% | -351 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -219↓10.6% | -198↓12.0% | -176↑9.7% | -195↓178.7% | 248 | |
| Net Cash from Financing Activities | -473↑20.2% | -592↑7.8% | -642↓85.1% | -347↓16.3% | -298 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | 24↑448.8% | -7↑92.0% | -85↓156.9% | 149↑2311.1% | -7 | |
| Cash at Beginning of Period | 48↓12.5% | 54↓60.9% | 139↑1537.0% | -10↓228.0% | -3 | |
| Cash at End of Period | 71↑49.9% | 48↓12.5% | 54↓60.9% | 139↑1537.0% | -10 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | 512↑12.7% | 455↓9.5% | 502↑2.3% | 491↑40.2% | 350 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.